Chemo Pharma Laboratories

117.44
+2.30
(2.00%)
Market Cap
17.65 Cr
EPS
-9.66
PE Ratio
44.28
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
154.00
52 Week Low
55.10
PB Ratio
1.26
Debt to Equity
0.00
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,764.75 4,23,422.64 36.32 49,887.20 12.06 9,648 13.77 61.58
5,840.65 1,55,050.91 75.90 8,184.00 0.89 1,600 64.53 55.23
1,511.20 1,22,046.63 24.67 26,520.70 14.17 4,155 47.38 60.28
3,245.05 1,09,827.24 59.25 10,785.70 11.59 1,656 13.54 61.68
2,398.05 98,935.61 47.95 10,615.60 19.57 1,942 -16.38 56.07
1,177.90 98,285.26 18.80 28,905.40 12.36 5,578 1.69 51.86
2,068.75 94,375.87 33.76 20,141.50 19.94 1,936 38.82 54.50
907.35 91,300.64 20.56 19,831.50 13.82 3,831 29.92 48.54
1,194.95 69,402.89 19.93 29,559.20 17.55 3,169 -10.04 61.05
31,101.85 66,089.26 49.48 6,097.20 10.80 1,201 16.01 61.04
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-101.57 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2016
TTM
Revenue
-1
0
Expenses
0
0
EBITDA
-1
0
Operating Profit %
0 %
0 %
Depreciation
0
0
Interest
0
0
Profit Before Tax
-1
0
Tax
0
0
Net Profit
-1
0
EPS in ₹
-9.66
0.00

Balance Sheet

Balance Sheet
2016
Total Assets
4
Fixed Assets
0
Current Assets
2
Capital Work in Progress
0
Investments
0
Other Assets
4
Total Liabilities
4
Current Liabilities
0
Non Current Liabilities
0
Total Equity
4
Reserve & Surplus
2
Share Capital
2

Cash Flow

Cash Flow
2016
Net Cash Flow
0
Investing Activities
2
Operating Activities
-2
Financing Activities
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
27.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.28 %
0.17 %
0.17 %
0.17 %
0.17 %
0.17 %
0.37 %
0.37 %
0.37 %
0.17 %
0.37 %
0.17 %
0.37 %
0.37 %
0.37 %
0.37 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
65.76 %
65.77 %
65.51 %
65.70 %
65.74 %
65.72 %
65.57 %
65.38 %
65.40 %
65.56 %
65.55 %
65.51 %
65.61 %
65.63 %
65.60 %
65.50 %
Others
6.07 %
6.17 %
6.44 %
6.25 %
6.21 %
6.22 %
6.18 %
6.37 %
6.35 %
6.39 %
6.19 %
6.44 %
6.14 %
6.12 %
6.15 %
6.25 %
No of Share Holders
5,949
6,082
6,129
6,213
6,225
6,226
6,226
6,274
6,289
6,268
6,275
6,254
6,262
6,254
6,382
6,576

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Draft Letter of Offer
Feb 28, 2025
Draft Letter of Offer
Feb 28, 2025
Detailed Public Statement
Feb 24, 2025
Intimation Of Signing Of Share Purchase Agreement (SPA) Between The Promoter & Promoter Group And Acquirer
Feb 18, 2025
Submission Of Public Announcement To The Public Shareholders Of M/S Chemo Pharma Laboratories Limited
Feb 18, 2025
Public Announcement - Open Offer
Feb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 28, 2025
Integrated Filing (Financial)
Jan 27, 2025
Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024
Jan 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday January 27 2025
Jan 27, 2025
Board Meeting Intimation for Board Meeting To Be Held On Monday January 27 2025
Jan 13, 2025
Announcement under Regulation 30 (LODR)-Change in Management
Dec 31, 2024
Closure of Trading Window
Dec 31, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 29, 2024
Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024
Oct 28, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, October 28, 2024
Oct 28, 2024
Board Meeting Intimation for Board Meeting To Be Held On Monday, October 28, 2024
Oct 15, 2024
Reply To The Clarification Sought On Movement In Price Of The Shares Across Exchanges Of Shares Of The Company
Oct 14, 2024
Clarification sought from Chemo Pharma Laboratories Ltd
Oct 11, 2024
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Oct 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 01, 2024
Closure of Trading Window
Sep 30, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 24, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 02, 2024
Reg. 34 (1) Annual Report.
Aug 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jul 31, 2024
Intimation Of Book Closure And Record Date For The Annual General Meeting To Be Held For The Financial Year 2023-2024
Jul 29, 2024
Submission Of Un-Audited Financial Results For The Quarter Ended June 30, 2024
Jul 29, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, July 29, 2024
Jul 29, 2024
Board Meeting Intimation for Board Meeting To Be Held On Monday, July 29, 2024
Jul 09, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 02, 2024
Closure of Trading Window
Jun 28, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jun 10, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
May 28, 2024
Appointment Of M/S. Sarda Soni Associates LLP As An Internal Auditor For The Financial Year 2024-2025
May 27, 2024
Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024
May 27, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, May 27, 2024
May 27, 2024
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
May 15, 2024
Board Meeting Intimation for Board Meeting To Be Held On Monday, May 27, 2024
May 10, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
May 07, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Apr 23, 2024
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2024
Apr 11, 2024
Compliances-Reg.24(A)-Annual Secretarial Compliance
Apr 05, 2024
Compliance Certificate Pursuant To Regulation 7(3) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2024
Apr 05, 2024
Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Apr 02, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Apr 02, 2024
Closure of Trading Window
Mar 28, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 30, 2024

Technical Indicators

RSI(14)
Overbought
85.03
ATR(14)
Less Volatile
2.74
STOCH(9,6)
Overbought
97.13
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
1.89
ADX(14)
Strong Trend
47.01
UO(9)
Bearish
84.96
ROC(12)
Uptrend But Slowing Down
23.63
WillR(14)
Overbought
-8.80